Structural and analytical characterization of three hydrates and an anhydrate form of risedronate

Journal of Pharmaceutical Sciences

Volumn 94, Issue 4, 2005, Pages 893-911

  Redman Furey, Nancy ^a   Dicks, Michael ^a   Bigalow Kern, Adrienne ^a   Cambron, R Thomas ^a   Lubey, Gwen ^a   Lester, Cathy ^a   Vaughn, Dana ^a  

^a PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

FTIR; Hemi pentahydrate; Hydrate; Monohydrate; Raman spectroscopy; Risedronate; Solid state; Solid state NMR; Thermal analysis; X ray diffractometry

Indexed keywords

RISEDRONIC ACID;

ARTICLE; CRYSTALLIZATION; DRUG FORMULATION; DRUG STRUCTURE; HYDRATION; RAMAN SPECTROMETRY; ROOM TEMPERATURE; SIMULATION; STRUCTURE ANALYSIS; THERMAL ANALYSIS; X RAY POWDER DIFFRACTION;

EID: 17744375635     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20308     Document Type: Article

References (39)

1. Morris KR. 1999. Structured aspects of hydrates and solvates. In: Brittain HG, editor. Polymorphism and pharmaceutical solids, drugs and the pharmaceutical sciences, Vol. 95. New York: Marcel Dekker, pp 125-181.
2. Khankari RK, Grant DJW. 1995. Pharmaceutical hydrates. Thermochim Acta 248:61-79.
3. Galwey AK. 2000. Structure and order in thermal dehydrations of crystalline solids. Thermochim Acta 355:181-238.
4. Morris KR, Griesser UJ, Eckhardt CJ. 2001. Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. Adv Drug Deliv Rev 48:91-114.
5. Redman-Furey NL, Collins WJ, Burgin MA. 2002. Thermoanalytical characterization of the hydration states of Risedronate. Proceedings of the 30th NATAS conference, Pittsburgh, PA, pp 733-738.
6. Collins WJ, Dicks ML, Redman-Furey NL, Godlewski J, Vaughn DC. 2003. The role of TG/DTA in the initial evaluation of the solid state forms for pharmaceutical new chemical entities part II: Evaluation of mixed forms. Proceedings of the 31st NATAS conference, Albuquerque, NM. Paper 90.
7. Collins WJ, Bigalow-Kern AS, Cambron RT, Redman-Furey NL. 2003. Use of a TG/DTA/Raman system to monitor desolvation and phase conversions. Proceedings of the 31st NATAS conference, Albuquerque, NM. Paper 29.25.
8. Dicks ML. 2004. Unpublished results. Structure determination of risedronate anhydrate, Internal Report. P&GP.
9. Skowron A. 2004. Unpublished results. Crystal structure determination of risedronate salt monohydrate.
10. Skowron A. 2004. Unpublished results. Crystal structure determination of risedronate hemi-pentahydrate.
11. Andrews ER, Bradbury A, Eades RG. 1959. Removal of dipolar broadening of nuclear magnetic resonance spectra of solids by specimen rotation. Nature 183:1802-1803.
12. Lowe IJ. 1959. Free induction decays of rotating solids. Phys Rev Lett 2:285-287.
13. Pines A, Gibby MG, Waugh JS. 1972. Proton-enhanced nuclear induction spectroscopy. A method for high resolution NMR of dilute spins in solids. J Chem Phys 56:1776-1777.
14. Pines A, Gibby MG, Waugh JS. 1973. Proton-enhanced NMR of dilute spins in solids. J Chem Phys 59:569-590.
15. Schaefer J, Stejskal EO. 1976. 13C NMR of polymers spinning at the magic angle. J Am Chem Soc 98:1031-1032.
16. Bruch MD, editor. 1996. NMR spectroscopy techniques. Practical spectroscopy Series vol 21, 2nd ed. New York: Marcel Dekker, Inc., p 443.
17. Hartman SR, Hahn EL. 1962. Nuclear double resonance in the rotating frame. Phys Rev 128:2042-2053.
18. Dixon WT, Schaefer J, Sefcik MD, Stejskal EO, McKay RA. 1982. Total suppression of sidebands in CPMAS C-13 NMR. J Magn Reson 49:341-345.
19. Opella SJ, Frey MH. 1979. Selection of nonprotonated carbon resonances in solid-state nuclear magnetic resonance. J Am Chem Soc 101:5854-5856.
20. Gossman WL, Wilson SR, Oldfield E. 2003. Three hydrates of the bisphosphonate risedronate, consisting of one molecular and two ionic structures. Acta Chrystallogr C 59:m33-m36.
21. Skowron A. 2004. Unpublished results. Crystal structure determination of risedronate higher hydrate.
22. Jenkins R, Snyder RL. 1996. Introduction to X-ray powder diffraction. In: Winefordner JD, editor. Chemical analysis, a series of monographs on analytical chemistry and its applications, vol. 138. New York: John Wiley & Sons, Inc., pp 319-351.
23. Pelletier MJ. 1999. Introduction to applied raman spectroscopy, and raman instrumentation. In: Pelletier MJ, editor. Analytical applications of raman spectroscopy. Oxford, England: Blackwell Science, pp 1-97.
24. Wang F, Wachter JA, Antosz FJ, Berglund KA. 2000. An investigation of solvent-mediated polymorphic transformation of progesterone using in situ raman spectroscopy. Organic Process Res Dev 4:391-395.
25. De Jager HJ, Prinsloo LC. 2001. The dehydration of phospates monitored by DSC/TGA and in situ Raman spectroscopy. Thermochim Acta 376:187-196.
26. Brittain HG, Morris KR, Bugay DE, Thakur AB, Serajuddin TM. 1993. Solid-state NMR and IR for the analysis of pharmaceutical solids: Polymorphs of fosinopril sodium. J Pharmaceut Biomed Anal 11:1063-1069.
27. Langkilde FW, Sjoblom J, Tekenbergs-Hjelte L, Mrak J. 1997. Quantitative FT-Raman analysis of two crystal forms of a pharmaceutical compound. J Pharmaceut Biomed Anal 15:687-696.
28. Terol A, Cassanas G, Nurit J, Pauvert B, Bouassab A, Rambaud J, Chevallet P. 1994. Infrared, Raman, and 13C NMR Spectra of two crystalline forms of (IR, 3S)-3-(p-Thioanisoyl)-1,2,2-trimethylcyclopentanecarboxylic Acid. J Pharmaceut Sci 83:1437-1442.
29. Kobayashi M, Adachi T. 1995. Polymorphism and phase transitions of linear oligomers of polytetrafluoroethylene revealed by vibrational spectroscopy. J Phys Chem 99:4609-4619.
30. Lin-Vien D, Colthup NB, Fateley WG, Grasselli JG. 1991. The handbook of infrared and raman characteristic frequencies of organic molecules. San Diego, CA: Academic Press.
31. Nyquist RA. 1966. The vibrational spectra of trimethyl phosphite. Spectrochim Acta 22:1315-1323.
32. Baranska M, Weselucha-Birczynska A, Chruszez-Lipska K, Proniewicz LM. 2004. FT-Raman study of (hydroxypyridin-3-yl-methyl)phosphonic acid with varying pH 2D correlation method. Vibrational Spectroscopy 35:233-237.
33. Vuano BM, Acebal SG, Sala O, Brieux O, Pieroni OI. 2004. 2-Hydroxy-2-oxo-1,4,2-oxa-aza-phospha(V) cyclohexane-4-methylene phosphonic acid (OAPhMPh): Its structure and symmetry by vibrational spectroscopy. J Mol Struct 690:77-81.
34. Klots TD. 1998. Raman vapor spectrum and vibrational assignment for pyridine. Spectrochim Acta 54:1481-1498.
35. Hunter BK, Sanders JKM. 1989. Modern NMR spectroscopy: A guide for chemists. New York: Oxford University Press.
36. Bruch MD, editor. 1996. NMR spectroscopy techniques. Practical spectroscopy series vol 21, 2nd ed. New York: Marcel Dekker, Inc.
37. 31P CP/MAS NMR study on dehydration of disodium clodronate tetrahydrate. Pharmaceut Res 15:110-115.
38. 31P NMR chemical shifts and structural parameters in crystalline inorganic phosphates. J Chem Soc Chem Commun 3:195-197.
39. Gorenstein DG. 1983. Non-biological aspects of phosphorus-31 NMR spectroscopy. Prog NMR Spectres 16:1-98.